4 results match your criteria: "Nigeria. afukonyoshidoiku@tsuniversity.edu.ng.[Affiliation]"
BMC Cardiovasc Disord
January 2025
SR Sanjeevani Hospital, 56517, Kalyanpur, Siraha, Nepal.
Background: Atrial fibrillation (AF) is the most prevalent form of sustained cardiac arrhythmia, with vascular endothelial growth factor (VEGF) increasingly recognized for its potential role in the pathogenesis of AF through mechanisms involving atrial remodeling, inflammation, and fibrosis. This systematic review aims to synthesize available evidence on the association between VEGF and AF, exploring the implications of VEGF as a biomarker and therapeutic target.
Methods: We conducted a comprehensive search across PubMed, Embase, and Web of Science until November 10 2024, selecting studies based on pre-defined criteria that involve adults with AF and measurements of VEGF levels.
BMC Public Health
November 2024
Global Health and Infectious Diseases Control Institute, Nasarawa State University, Keffi, Nigeria.
BMC Cardiovasc Disord
November 2024
Global Health and Infectious Diseases Control Institute, Nasarawa State University, Keffi, Nigeria.
BMC Endocr Disord
November 2024
Center for Global Health Research, Saveetha Institute of Medical and Technical Sciences, Saveetha Medical College and Hospital, Saveetha University, Chennai, India.
Background: Hepatocellular carcinoma (HCC) is a major cause of cancer-related mortality worldwide, with increased prevalence in individuals with chronic liver conditions and type 2 diabetes mellitus (T2DM). Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) have shown promise in diabetes management and may influence liver disease progression. This systematic review and meta-analysis aimed to assess the efficacy of GLP-1 RAs in reducing the risk of HCC in patients with T2DM.
View Article and Find Full Text PDF